期刊文献+

双侧丘脑底核电刺激对帕金森病患者脑局部糖代谢的影响 被引量:1

The effect of bilateral subthalamic nucleus stimulation on glocose metabolism of cerebrum in advanced Parkinson's di- sease.
下载PDF
导出
摘要 目的 研究双侧丘脑底核(subthalamic nucleus,STN)慢性电刺激术(deep brain stimulation,DBS)对晚期帕金森病(Parkinson's disease,PD)患者静止期脑局部糖代谢的影响,并探讨其作用机制。方法 对5例进行双侧STN的DBS治疗的晚期帕金森病患者,分别在术前以及术后1个月电刺激条件下,进行静止期18F-脱氧葡萄糖(FDG)/PET检查和UPDRS运动评分,并通过SPM99统计学软件进行数据分析,比较STN的DBS治疗对脑内代谢的影响。结果 双侧STN的DBS治疗使PD患者临床症状明显改善,同时脑局部糖代谢也发生了明显变化:双侧豆状核、脑干(中脑、脑桥)、双侧顶枕部、运动前区(BA6)及扣带回的脑代谢增加,双侧前额叶底部海马的脑代谢明显减少(P<0.05)。结论 双侧STN的DBS治疗可能通过兴奋STN轴突的方式,使其投射区域的基底上行和下行通路以及相应的皮层高级中枢的代谢改善,从而使PD患者的临床症状改善。 Objective To study the effect of bilateral subthalamic nucleus (STN) stimulation on resting-state cerebral glucose metabolism of advanced Parkinson's disease, and investigate the mechanism of deep brain stimulation (DBS). Methods Five consecutive advanced Parkinson's disease patients with bilateral STN DBS underwent 2 times F-FDG/PET examinations at resting-state preoperatively and one month postoperatively with STN stimulation. The UPDRS motor scale was used to investigate regional cerebral metabolic rate of glucose (rCMRGlu) during STN stimulation in comparison with rCMRGlu preoperatively. Results STN stimulation significantly improved the clinical symptoms: rCMRGlu increased in left globus pallidus, upper brainstem (right midbrain) , bilateral parietal-occipital cortex, and decreased in the bottom of both prefrontal cortex ( P < 0.001). Conclusions Bilateral STN stimulation activated the projection axon from STN and improved the clinical symptoms of advanced PD patients, which perhaps by the way of improving both ascending and descending pathway from the basal ganglia and increasing the metabolism of higher-order motor control of parietal-occipital cortex.
出处 《中国神经精神疾病杂志》 CAS CSCD 北大核心 2003年第6期414-417,共4页 Chinese Journal of Nervous and Mental Diseases
基金 国家自然科学基金(编号:30270493)
关键词 双侧丘脑底核电刺激 帕金森病 脑局部糖代谢 手术方法 Parkinson's disease Deep brain stimulation Subthalamic nucleus Positron emission tomography(PET) Fluorodeoxyglucose (FDG)
  • 相关文献

参考文献2

二级参考文献32

  • 1[2]Filion M, Tremblay L. Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP- induced parkinsonism. Brain Research,1991, 547(1):142- 151.
  • 2[3]Wichmann T, Bergman H, DeLong MR. The primate subthalamic nucleus. Ⅲ. Changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactiviation in the MPTP model of parkinsonism. 1994, 72(2): 521-530.
  • 3[4]Bergman H, Wichmann T, DeLong MR. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. 1990, 249(4975): 1436 -1438.
  • 4[5]Gill SS, Heywood P. Bilateral dorsolateral .subthalamotomy for advanced Parkinson's disease. Lancet, 1997, 350(9086): 1224.
  • 5[6]Lang AE, Lozano AM, Montgomery E, et al. Posteroventral medial pallidotomy in advanced Parkinson's disease. New England Journal of Medicine, 1997, 337(15): 1036- 1042.
  • 6[7]Limousin P, Krack P, Pollak P, et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease, New England Jouma of Medicine 1998, 339(16): 1105- 1115.
  • 7[8]Schuurman PR, Bosch DA, Bossuyt PM, et al. A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. New England Journal of Medicine, 2000, 342(7): 461 - 468(in comments).
  • 8[9]Koller W, Pahwa R, Busenlark K, et al. High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor.Ann of Neurol, 1997, 42(3): 292 - 299.
  • 9[10]Limousin P, Speelman JD, Gieleu F, et al. Multieentre European study of thalamic stimulation in parkinsonian and essential tremor. J Neurol Neurosurg Psychiatry, 1999, 66(3): 289 - 296.
  • 10[11]Langston JW, Ballard P, Tetrud JW, et al. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science,1983, 219(4587): 979-980.

共引文献39

同被引文献15

  • 1王新德.帕金森病及帕金森综合征的诊断标准和鉴别诊断[J].中华神经精神科杂志,1985,18(4):256-256.
  • 2Kuopio AM, Marttila R J, Helenius H, et al. The quality of life in Parkinson's disease. Mov Disord, 2000, 15(2): 216.
  • 3Limousin P, Krack P, Pollak P, et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med, 1998,339(16): 1105.
  • 4Germano IM, Gracies JM, Weisz DJ, et al. Unilateral stimulation of the subthalamic nucleus in Parkinson disease: a double-blind 12-month evaluation study. J Neunsurg, 2004, 101(1): 36.
  • 5Fahn S, Elton RL. Members of the UPDRS development committee: Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne DB, et al editors. Recent development in Parkinson's disease. 2nd ed.Florham Park, NJ: MacMillan Healthcare Information, 1987. 153.
  • 6Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality.Neurology, 1967, 17(5): 427.
  • 7Schwab RS, England AC. Projection technique for evaluating surgery in Pankinson's disease. In: Gillingham FJ, Donaldson IML, editors. Third Symposium on Parkinson's Disease. Edinburgh: E and S Livingstone,1969. 152.
  • 8Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand, 1983, 67(6): 361.
  • 9Jenkinson C, Fitzpatrick R, Peto V, et al. The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score. Age Ageing, 1997, 26(5): 353.
  • 10Tsang KL, Chi I, Ho SL, et al. Translation and validation of the standard Chinese version of PDQ-39: a quality-of-life measure for patients with Parkinson's disease. Mov Disord, 2002, 17(5): 1036.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部